1636P Health-related quality of life outcomes of androgen receptor pathway inhibitors versus taxanes versus standard of care in metastatic castration-resistant prostate cancer: Results from the ProBio trial
| Autor: | Bultijnck, R. 1, Strijbos, M.H. 2, Mortezavi, A. 3, Lindberg, J. 4, Discacciati, A. 4, Karlsson, C.T. 5, Ullén, A. 6, Jänes, E. 7, Enblad, G. 8, Oldenburg, J. 9, Sautois, B. 10, Hjälm-Eriksson, M.E. 11, Sagstuen Haugnes, H. 12, Schatteman, P. 13, Ghysel, C. 14, De Laere, B. 1, Eklund, M. 4, Grönberg, H. 15, Ost, P. 16, Crippa, A. 4 |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S987-S987 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|